Review Article | DOI: https://doi.org/10.31579/2640-1053/265
¹PhD Scholar, Teaching Staff School of Pharmacy, RK University, Rajkot, Gujarat, India.
²Research Scholar, School of Pharmacy, RK University, Rajkot, Gujarat, India.
*Corresponding Author: Chinmyee Saha., PhD Scholar, Teaching Staff School of Pharmacy, RK University, Rajkot, Gujarat, India.
Citation: Chinmyee Saha, Jeffrey E. Sampson, (2026), Sulforaphane’s Rhythm: A Natural Note in Cancer’s Downfall, J. Cancer Research and Cellular Therapeutics. 10(3); DOI:10.31579/2640-1053/265
Copyright: © 2026, Chinmyee Saha. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 26 June 2026 | Accepted: 06 July 2026 | Published: 24 July 2026
Keywords: sulforaphane (sfn); cervical cancer; human papillomavirus (hpv); apoptosis; cell cycle arrest; nrf2/nf-κb signaling; oxidative stress; chemoprevention etc
Sulforaphane (SFN), a phytochemical constituent of cruciferous vegetables, has emerged as a compelling candidate in the therapeutic landscape of cervical carcinoma. Exhibiting selective cytotoxicity, SFN orchestrates apoptosis and cell cycle arrest via modulation of pivotal signaling cascades, including JNK/p38 MAPK and Wnt/β-catenin, while concurrently attenuating cancer stem cell phenotypes. It augments radiosensitivity by compromising DNA repair fidelity through inhibition of Rad51 and MDC1, thereby potentiating radiotherapeutic outcomes. SFN further exerts epigenetic influence by regulating microRNAs such as miR-1247-3p and modulating chromatin architecture, culminating in transcriptional repression of oncogenic drivers. The article represents a comprehensive elucidation of SFN’s pleiotropic mechanisms, with particular emphasis on its capacity to counteract HPV-mediated inflammation through Nrf2 activation and NF-κB suppression—key modulators of oxidative and inflammatory stress in cervical oncogenesis. Preclinical investigations substantiate its antitumor efficacy with negligible off-target toxicity. Owing to its favorable pharmacokinetic profile, dietary accessibility, and minimal adverse effects, SFN holds promise as both a chemopreventive and adjunctive therapeutic agent. This synthesis underscores SFN’s potential to surmount therapeutic resistance and recurrence, advocating for its integration into future multimodal cervical cancer regimens pending rigorous clinical validation.
Cervical cancer remains a major global health concern, particularly in developing countries where access to HPV vaccination and early screening is limited. Despite advances in chemotherapy and radiotherapy, treatment efficacy is often hindered by drug resistance, toxicity, and recurrence. This has led to increased interest in bioactive phytochemicals with anticancer potential. Sulforaphane (SFN), a naturally occurring isothiocyanate found in cruciferous vegetables such as broccoli and Brussels sprouts, has demonstrated promising anticancer effects across various malignancies, including cervical cancer. SFN induces G2/M phase cell cycle arrest in cervical cancer cells by downregulating Cyclin B1 and promoting the formation of the GADD45β/CDC2 complex, thereby delaying mitosis and suppressing proliferation [1]. In addition to cell cycle modulation, SFN influences apoptotic pathways through the MAPK signaling cascade, mediated by the downregulation of miR-1247-3p, leading to increased apoptosis and reduced viability in HeLa cells [2]. These molecular interactions highlight SFN’s ability to reprogram oncogenic signaling and promote programmed cell death. Furthermore, SFN has shown synergistic effects when combined with conventional chemotherapeutic agents such as cisplatin and 5-fluorouracil, enhancing cytotoxicity while reducing adverse effects [3]. This combinational approach suggests that SFN may serve as an effective adjuvant in cervical cancer therapy. Taken together, these findings underscore the therapeutic potential of Sulforaphane as a multi-targeted agent in cervical cancer management, warranting further preclinical and clinical investigation.
2.1. Induces apoptosis via mitochondrial dysfunction:
Sulforaphane (SFN) induces apoptosis in cervical cancer cells primarily through mitochondrial dysfunction and activation of intrinsic apoptotic pathways. Upon SFN treatment, HeLa cells exhibit hallmark features of apoptosis, including chromatin condensation, formation of apoptotic bodies, and accumulation in the sub-G1 phase of the cell cycle [4]. Mechanistically, SFN downregulates anti-apoptotic proteins such as Bcl-2 and Bcl-xL, while upregulating pro-apoptotic Bax, thereby disrupting mitochondrial membrane potential and promoting cytochrome c release. This mitochondrial imbalance leads to the activation of caspase-9, followed by caspase-3, culminating in the cleavage of poly (ADP-ribose) polymerase (PARP) and β-catenin, which are critical for DNA repair and cell adhesion, respectively [4]. Importantly, the use of z-DEVD-fmk, a caspase-3 specific inhibitor, significantly attenuates SFN-induced apoptosis, confirming the central role of caspase-3 in this process. These findings underscore SFN’s ability to trigger intrinsic apoptotic signaling via mitochondrial destabilization, making it a promising candidate for targeted cervical cancer therapy.
2.2. Caspase Activation by Sulforaphane:
Sulforaphane (SFN) initiates apoptosis in cervical cancer cells through the intrinsic mitochondrial pathway, prominently involving the activation of Caspase-9 and Caspase-3. SFN disrupts mitochondrial membrane integrity, leading to the release of cytochrome c into the cytosol. This event triggers the formation of the apoptosome complex, which activates Caspase-9, the initiator caspase of the intrinsic pathway [5]. Activated Caspase-9 subsequently cleaves and activates Caspase-3, the key executioner caspase responsible for dismantling cellular structures. SFN-treated HeLa cells exhibit cleavage of poly (ADP-ribose) polymerase (PARP) and β-catenin, both substrates of Caspase-3, confirming its activation [5], [6]. These molecular events are accompanied by chromatin condensation, DNA fragmentation, and formation of apoptotic bodies—hallmarks of programmed cell death. Importantly, the use of z-DEVD-fmk, a Caspase-3-specific inhibitor, significantly reduces SFN-induced apoptosis, validating the central role of Caspase-3 in SFN-mediated cytotoxicity [5]. Additional studies have shown that SFN also upregulates Bax and downregulates Bcl-2, further amplifying mitochondrial dysfunction and caspase activation [6,7]. These findings collectively highlight SFN’s ability to trigger apoptosis via a well-orchestrated caspase cascade, reinforcing its potential as a targeted therapeutic agent in cervical cancer.
2.3. Nuclear Fragmentation & Chromatin Condensation
Sulforaphane (SFN) induces apoptosis in cervical cancer cells through both biochemical and morphological changes, including nuclear fragmentation and chromatin condensation—hallmarks of late-stage apoptosis. These changes are clearly observed in SFN-treated HeLa cells using DAPI staining and fluorescence microscopy, where nuclei appear condensed and fragmented [8]. Mechanistically, SFN activates the intrinsic apoptotic pathway, leading to mitochondrial dysfunction and release of cytochrome c, which triggers caspase-9 and subsequently caspase-3 activation. Caspase-3 cleaves nuclear substrates such as PARP and lamin proteins, resulting in disassembly of the nuclear envelope and DNA fragmentation [9]. Additionally, SFN influences epigenetic regulators such as HDAC1 and DNMT3B, which are involved in chromatin remodeling. By downregulating these enzymes, SFN promotes a more open chromatin structure that facilitates apoptotic signaling and nuclear breakdown [10]. These combined effects reinforce SFN’s role in orchestrating both molecular and structural dismantling of cancer cells.
2.4. Bax/Bcl-2 Ratio and Apoptotic Shift:
Sulforaphane (SFN) promotes apoptosis in cervical cancer cells by modulating the balance between pro-apoptotic and anti-apoptotic proteins—specifically by increasing the Bax/Bcl-2 ratio. This shift is critical in tipping the cellular fate toward programmed cell death. SFN upregulates Bax, a pro-apoptotic member of the Bcl-2 family, which promotes mitochondrial outer membrane permeabilization (MOMP). Concurrently, SFN downregulates Bcl-2, an anti-apoptotic protein that normally inhibits cytochrome c release and caspase activation. The resulting increase in the Bax/Bcl-2 ratio facilitates mitochondrial dysfunction, leading to the release of apoptogenic factors such as cytochrome c and apoptosis-inducing factor (AIF) [11]. Immunohistochemical studies in cervical squamous cell carcinoma have confirmed that Bax expression intensifies in invasive stages, while Bcl-2 expression is more prominent in pre-invasive lesions, suggesting SFN’s role in pushing cells beyond the survival threshold [12]. Moreover, genomic analyses have revealed missense mutations in the BAX gene and transitional mutations in Bcl-2, further implicating these proteins in cervical carcinogenesis and SFN’s therapeutic targeting [13]. This Bax/Bcl-2 modulation is a key mechanism by which SFN induces mitochondrial-mediated apoptosis, reinforcing its potential as a selective and effective anticancer agent.
2.5. Cytochrome c Release and Mitochondrial Apoptosis
Sulforaphane (SFN) promotes apoptosis in cervical cancer cells by triggering mitochondrial outer membrane permeabilization (MOMP), which leads to the release of cytochrome c into the cytosol—a pivotal event in the intrinsic apoptotic pathway. Once released, cytochrome c binds to Apaf-1, forming the apoptosome, which activates caspase-9, followed by caspase-3, initiating the execution phase of apoptosis [14].In HeLa cells treated with SFN, Western blot analysis confirms a dose-dependent increase in cytosolic cytochrome c, accompanied by upregulation of Bax and downregulation of Bcl-2, further destabilizing mitochondrial integrity [14]. This mitochondrial disruption is also associated with loss of membrane potential, as shown by JC-1 staining assays, and correlates with increased DNA fragmentation and apoptotic body formation. Additional studies in colon and oral squamous carcinoma cells support these findings, demonstrating that SFN-induced apoptosis involves cytochrome c release, PARP cleavage, and activation of mitochondrial caspases, reinforcing its role as a mitochondrial-targeting anticancer agent [15], [16].
2.6.ER Stress-Mediated Apoptosis Induced by Sulforaphane
Sulforaphane (SFN) induces apoptosis in cervical cancer cells not only through mitochondrial pathways but also by triggering endoplasmic reticulum (ER) stress, a critical cellular mechanism that responds to misfolded protein accumulation and calcium imbalance. In HeLa cells, SFN treatment leads to the upregulation of key ER stress markers such as GRP78, CHOP, and Caspase-12, indicating activation of the unfolded protein response (UPR) and subsequent apoptotic signaling [17].The ER stress pathway initiated by SFN involves three major sensors: PERK, IRE1, and ATF6. SFN activates PERK, which phosphorylates eIF2α, leading to selective translation of ATF4 and transcriptional activation of CHOP, a pro-apoptotic transcription factor. CHOP promotes mitochondrial dysfunction and enhances the expression of Bax, further amplifying apoptosis [18]. Additionally, SFN-induced ER stress activates Caspase-12, which is localized to the ER membrane and specifically mediates ER-associated apoptosis. This caspase cascade complements the mitochondrial pathway, resulting in robust and irreversible cell death in cervical cancer cells [19]. These findings underscore SFN’s ability to engage multiple apoptotic pathways, making it a potent and multifaceted anticancer agent.
Sulforaphane (SFN), a dietary isothiocyanate derived from cruciferous vegetables, has been shown to induce G2/M phase cell cycle arrest in various cancer types, including cervical cancer. Cheng et al. [20] demonstrated that SFN treatment in HeLa, Cx, and CxWJ cells leads to a dose-dependent accumulation of cells in the G2/M phase, mediated by downregulation of Cyclin B1 and upregulation of GADD45β, which disrupts the Cyclin B1/CDC2 complex essential for mitotic entry. This mechanism halts cell cycle progression and promotes mitotic delay. Complementing these findings, Chang et al. [21] showed that SFN induces G2/M arrest in ovarian cancer cells via CDC2 downregulation and dissociation of the Cyclin B1/CDC2 complex, suggesting a conserved mechanism across gynecological malignancies. Furthermore, Kamal et al. [22] reviewed SFN’s broader anticancer actions, highlighting its ability to arrest the cell cycle at both G1 and G2/M phases and enhance the efficacy of chemotherapeutics like paclitaxel and gemcitabine through synergistic interactions. Collectively, these studies underscore SFN’s potential as a chemopreventive and therapeutic agent targeting cell cycle checkpoints in cervical and other cancers.
3.2. Sulforaphane Downregulates Cyclin B1 and CDC2 to Induce G2/M Arrest:
Sulforaphane (SFN), a dietary isothiocyanate derived from cruciferous vegetables, exerts potent anticancer effects by targeting key regulators of the cell cycle. One of its most consistent mechanisms is the downregulation of Cyclin B1 and CDC2, which disrupts the Cyclin B1/CDC2 complex essential for mitotic entry and progression. In PA-1 ovarian cancer cells that SFN treatment leads to significant downregulation of both Cyclin B1 and CDC2, confirmed by western blot and co-immunoprecipitation. This disruption of the Cyclin B1/CDC2 complex results in metaphase arrest and impaired mitotic spindle formation, contributing to G2/M phase arrest.[23]In cervical cancer cells (HeLa, Cx, CxWJ), showing that SFN downregulates Cyclin B1, while CDC2 levels remain stable. However, SFN upregulates GADD45β, which binds CDC2 and inhibits its kinase activity, functionally mimicking CDC2 suppression and reinforcing mitotic delay.[24]. A study archived on Semantic Scholar confirmed that SFN delays cancer progression by downregulating Cyclin B1, dissociating the Cyclin B1/CDC2 complex, and upregulating GADD45 proteins, reinforcing G2/M arrest and apoptosis.[25] Additional mechanistic insights from Chang et al. (2013) emphasize SFN’s role in CDC2 kinase inhibition, which blocks phosphorylation of mitotic substrates and prevents chromosomal segregation. This reinforces SFN’s dual targeting of Cyclin B1 and CDC2 as a conserved anticancer strategy across gynecological malignancies.[26]
3.3. Sulforaphane Upregulates GADD45β and Disrupts Cell Cycle Progression
Sulforaphane (SFN), a bioactive compound derived from cruciferous vegetables, disrupts cell cycle progression by upregulating GADD45β, a stress-inducible gene involved in checkpoint control and DNA damage response. [27] demonstrated that SFX-01, a stabilized form of SFN, significantly increases GADD45β expression in models of myeloproliferative disorders, leading to inhibition of CDC2 (CDK1) activity and suppression of cyclin D1 via STAT1-mediated signaling, ultimately resulting in cell cycle arrest. In cervical cancer cells, [28] showed that SFN induces GADD45β in a dose-dependent manner, which binds directly to CDC2 and disrupts the Cyclin B1/CDC2 complex, a critical driver of G2/M transition. This interaction halts mitotic progression and reinforces SFN’s antiproliferative effects. Supporting these findings, [29] reported that SFN triggers ROS-dependent signaling in pancreatic cancer cells, activating GADD45β and contributing to sub-G1 accumulation and mitotic delay. Additionally, [30] observed SFN-induced cell cycle arrest and apoptosis in HT29 colon cancer cells, consistent with stress-responsive pathway activation, although GADD45β was not directly measured. Collectively, these studies highlight GADD45β as a central mediator of SFN-induced cell cycle disruption across diverse cancer models.
3.4. Sulforaphane Inhibits DNA Synthesis in S-Phase
Sulforaphane (SFN) has been shown to inhibit DNA synthesis by arresting cancer cells in the S-phase of the cell cycle, thereby suppressing proliferation and promoting apoptosis. Wang et al. [31] demonstrated that SFN induces S-phase arrest in gastric cancer cells via a p53-dependent mechanism, leading to upregulation of p21 and downregulation of CDK2, a key regulator of DNA replication. This disruption impairs the transition through S-phase and halts DNA synthesis. Supporting this, Abassi Joozdani et al. [32] showed that SFN directly interacts with DNA through groove binding and intercalation, altering DNA conformation and potentially interfering with replication machinery. In glioblastoma models, Li et al. [33] reported that SFN-cysteine analogs downregulate CDK4/CDK6 and disrupt tubulin polymerization, contributing to cell cycle arrest and impaired DNA synthesis. Additionally, Gamet-Payrastre et al. [34] observed SFN-induced cell cycle arrest in HT29 colon cancer cells, consistent with suppressed DNA replication and enhanced apoptotic signaling. Collectively, these findings confirm that SFN inhibits DNA synthesis during S-phase through both transcriptional regulation and direct molecular interference, reinforcing its role as a potent anticancer agent.
4.1. Downregulates miR-1247-3p, a key oncogenic microRNA:
Sulforaphane (SFN), a bioactive isothiocyanate derived from cruciferous vegetables, exerts anticancer effects by modulating key microRNAs, including miR-1247-3p, a known oncogenic regulator. In a pivotal study by Luo et al. [35], SFN treatment of HeLa cervical cancer cells led to significant downregulation of miR-1247-3p, resulting in activation of the MAPK signaling pathway, suppression of cell proliferation, and induction of apoptosis. Using next-generation sequencing (NGS), qRT-PCR, and Western blot analysis, the study confirmed that SFN disrupts the oncogenic function of miR-1247-3p, which normally suppresses MAPK pathway components. Further supporting this, Su et al. [36] reviewed SFN’s broader epigenetic mechanisms, highlighting its ability to modulate noncoding RNAs, including oncogenic microRNAs, through inhibition of DNA methyltransferases (DNMTs) and histone deacetylases (HDACs). These epigenetic changes restore tumor suppressor gene expression and disrupt malignant signaling networks. SFN’s impact on miR-1247-3p fits within this framework, suggesting a dual mechanism of transcriptional repression and post-transcriptional regulation. Additionally, emerging evidence from preclinical models [37] confirms that SFN-induced miRNA reprogramming contributes to its antiproliferative and pro-apoptotic effects across multiple cancer types. The consistent downregulation of miR-1247-3p and concurrent MAPK activation positions SFN as a promising candidate for miRNA-targeted therapy, especially in malignancies where miR-1247-3p is upregulated and drives tumor progression.
4.2. Sulforaphane Activates MAPK Signaling via miRNA Modulation
Sulforaphane (SFN), a bioactive compound from cruciferous vegetables, exerts anticancer effects by modulating microRNA expression and activating key signaling pathways such as MAPK (Mitogen-Activated Protein Kinase). In a foundational study by Luo et al. [38], SFN was shown to downregulate miR-1247-3p in HeLa cervical cancer cells, thereby relieving its inhibitory effect on MAPK pathway components. This led to increased phosphorylation of ERK and JNK, promoting apoptosis and suppressing proliferation. The study employed next-generation sequencing, qRT-PCR, and Western blotting to confirm that SFN’s anticancer activity is mediated through miRNA-dependent activation of MAPK signaling. Expanding on this, Wang et al. [39] demonstrated that SFN modulates dendritic cell function through microRNA regulation, including suppression of miR-155-5p and induction of miR-194-5p, which indirectly influence MAPK and JAK/STAT3 signaling. Although focused on immune cells, this study reinforces the concept that SFN’s miRNA-mediated signaling modulation is a generalizable mechanism across cell types. Su et al. [40] further reviewed SFN’s epigenetic mechanisms, highlighting its ability to inhibit DNA methyltransferases (DNMTs) and histone deacetylases (HDACs), thereby altering the expression of noncoding RNAs such as microRNAs. This epigenetic reprogramming contributes to the reactivation of tumor suppressor pathways and the activation of MAPK signaling, positioning SFN as a multifaceted therapeutic agent. Together, these studies confirm that SFN activates MAPK signaling through targeted miRNA suppression and epigenetic remodeling, offering a promising strategy for cancer therapy.
4.3. Alters expression of tumor suppressor genes (e.g., p53):
Sulforaphane Alters Expression of Tumor Suppressor Genes (e.g., p53)
Sulforaphane (SFN), a naturally occurring isothiocyanate, has been shown to modulate the expression of key tumor suppressor genes, notably p53, which plays a central role in cell cycle regulation, DNA repair, and apoptosis. In a recent study by Li et al. [41], SFN treatment in glioblastoma cells led to significant transcriptional changes, including upregulation of p53-associated apoptotic pathways. RNA sequencing and qPCR analyses revealed that SFN activated stress-responsive genes and enhanced nuclear localization of p53 downstream effectors, contributing to apoptotic cell death. This effect was linked to SFN-induced endoplasmic reticulum stress and unfolded protein response (UPR), which indirectly stabilized p53 activity. Complementing this, Gwon et al. [42] demonstrated that SFN influences colorectal cancer cell proliferation through Nrf2 activation in a p53-dependent manner. In HCT116 cells expressing wild-type p53, SFN promoted mitochondrial biogenesis and reduced apoptosis, whereas in p53-knockout cells, SFN enhanced apoptotic signaling. These findings suggest that SFN’s impact on p53 is context-dependent, capable of either promoting survival or triggering cell death based on cellular stress thresholds. Further mechanistic insights are provided by Lenzi et al. [43], who reviewed SFN’s pleiotropic effects across cancer models. They noted that SFN exerts cytostatic and cytotoxic effects through modulation of multiple molecular targets, including p53, and that its efficacy is not strictly dependent on p53 mutation status. SFN was shown to potentiate chemotherapy-induced cytotoxicity and reinforce tumor suppressor pathways, making it a promising adjunct in cancer therapy.
4.4. Sulforaphane Modulates Histone Acetylation and Methylation Patterns:
Sulforaphane (SFN), a potent isothiocyanate derived from cruciferous vegetables, exerts significant epigenetic effects by altering histone acetylation and methylation, thereby influencing gene expression in cancer cells. [44] demonstrated that SFN inhibits histone deacetylases (HDACs), leading to increased acetylation of histone H3 and H4 tails. This chromatin relaxation facilitates transcriptional activation of tumor suppressor genes such as p21 and Bax, contributing to cell cycle arrest and apoptosis. Building on this, explored SFN’s effects in malignant melanoma, showing that SFN not only reduces HDAC activity but also modulates histone acetyltransferases (HATs) and histone methyltransferases (HMTs)[45] . Their findings revealed SFN-induced changes in lysine acetylation and methylation marks, such as H3K9ac, H3K4me3, and H3K27me3, which are critical for regulating transcriptional accessibility. These modifications were associated with reduced cell viability and enhanced apoptotic signaling, underscoring SFN’s therapeutic potential. The interdependence between histone modifications and DNA methylation. SFN was shown to reverse promoter hypermethylation and restore active chromatin states, particularly in genes involved in cell cycle regulation and differentiation.[46] The compound’s ability to simultaneously modulate multiple epigenetic layers positions it as a promising agent for nutritional epigenetic therapy and cancer chemoprevention.
4.5. Proliferation & Migration
Suppresses proliferation of HeLa cells (dose-dependent):
Sulforaphane Suppresses Proliferation and Migration of HeLa Cells (Dose-Dependent)
Sulforaphane (SFN) exhibits potent antiproliferative and antimigratory effects on HeLa cervical cancer cells, with its efficacy increasing in a dose-dependent manner. [47], SFN significantly reduced HeLa cell viability by modulating key molecular targets involved in cell cycle progression, apoptosis, and epigenetic regulation. Quantitative PCR analysis revealed downregulation of proliferation-associated genes such as cyclin B1, CDK1, and c-Myc, while upregulating tumor suppressors like p21 and Bax. SFN also inhibited the activity of DNA methyltransferases (DNMTs) and histone deacetylases (HDACs), leading to chromatin remodeling and re-expression of silenced apoptotic genes. SFN induces cell cycle arrest and apoptosis in a dose-dependent fashion, mediated by reactive oxygen species (ROS) accumulation and mitochondrial dysfunction[48]. In HeLa cells, SFN treatment elevated levels of cleaved caspase-3 and PARP, while reducing mitochondrial membrane potential and increasing γH2AX expression, indicative of DNA damage. These effects were reversed by ROS scavengers, confirming the role of oxidative stress in SFN-induced cytotoxicity. SFN’s broader anticancer mechanisms, emphasizing its ability to suppress migration and invasion through inhibition of epithelial-mesenchymal transition (EMT) markers such as Snail, Twist, and MMP-9. In HeLa cells, SFN reduced migratory capacity by downregulating matrix metalloproteinases and interfering with cytoskeletal dynamics[49]. These findings collectively support SFN’s dual role in inhibiting proliferation and migration, making it a promising candidate for cervical cancer chemoprevention and therapy.
4.6. Sulforaphane Reduces Colony Formation Capacity
Sulforaphane (SFN) significantly impairs the colony-forming ability of cancer cells, reflecting its potent anti-proliferative and cytotoxic properties. As demonstrated by Wang et al. [53], SFN treatment in gastric cancer (GC) cell lines BGC-823 and MGC-803 led to a marked reduction in colony formation in a dose-dependent manner. This suppression was attributed to SFN-induced S-phase cell cycle arrest and apoptosis, mediated through a p53-dependent pathway. Western blot analysis revealed increased expression of p53, p21, Bax, and cleaved caspase-3, alongside decreased levels of CDK2, indicating disruption of cell cycle progression and activation of apoptotic machinery. Building on this, Cho et al. [54] reported similar findings in pancreatic cancer cells, where SFN reduced clonogenic survival by triggering ROS-mediated DNA damage and mitochondrial dysfunction. SFN treatment elevated γH2AX levels and disrupted mitochondrial membrane potential, leading to irreversible cell cycle arrest and apoptosis. These effects were reversed by antioxidant pretreatment, confirming the role of oxidative stress in SFN’s anti-colony-forming action. Furthermore, Liu et al. [55] reviewed SFN’s broad-spectrum anticancer effects, highlighting its ability to inhibit anchorage-independent growth in soft agar assays across multiple cancer types. SFN was shown to interfere with oncogenic signaling pathways such as PI3K/Akt and MAPK, further contributing to its suppression of colony formation and tumorigenic potential.
4.7. Sulforaphane Impairs Cytoskeletal Dynamics via Ezrin Downregulation:
Sulforaphane (SFN) disrupts cancer cell motility and structural integrity by impairing cytoskeletal dynamics, primarily through the downregulation of Ezrin, a key membrane-cytoskeleton linker protein. As reported by Coutinho et al. [56], SFN treatment in cancer stem cells (CSCs) led to significant suppression of Ezrin expression, which in turn destabilized actin filament organization and impaired cellular polarity. Ezrin, a member of the ERM (Ezrin-Radixin-Moesin) family, is crucial for anchoring the actin cytoskeleton to the plasma membrane and facilitating signal transduction pathways that regulate migration and invasion. SFN-induced Ezrin downregulation was associated with reduced filopodia formation and diminished focal adhesion assembly, thereby limiting metastatic potential. Building on this, Mundy [57] investigated SFN’s effects on microtubule dynamics and centrosome positioning in epithelial cancer cells. The study revealed that SFN interferes with tubulin polymerization, alters centrosome orientation, and reduces cell velocity and directionality in scratch wound assays. These cytoskeletal disruptions were accompanied by changes in upstream regulators such as Rap1GAP, a tumor suppressor that modulates cell adhesion and migration. The combined effect of Ezrin suppression and microtubule destabilization contributes to SFN’s robust anti-migratory and anti-invasive profile. Together, these findings underscore SFN’s ability to target structural and signaling components of the cytoskeleton, making it a promising agent for anti-metastatic therapy in epithelial cancers.
5.1. Sulforaphane Enhances Efficacy of Chemotherapeutics (e.g., Docetaxel)
Sulforaphane (SFN) has demonstrated synergistic anticancer effects when combined with conventional chemotherapeutics, notably docetaxel (DCT). As reported by Peñata-Taborda et al. [58], low-dose SFN combined with DCT significantly enhanced therapeutic efficacy in prostate cancer cell lines (LNCaP and PC-3). The SFN:DCT combination reduced cell viability to levels comparable with DCT monotherapy, but at half the IC₅₀ concentration, indicating a potentiating effect. Mechanistically, SFN amplified caspase-3 activation (2.4 ± 0.75 RFU vs. 2.1 ± 0.47 RFU for DCT alone), increased ROS production, and reduced mitochondrial mass, suggesting that SFN sensitizes cancer cells to docetaxel by targeting metabolic vulnerabilities and apoptotic pathways. Building on this, Kim et al. [59] explored SFN’s role in triple-negative breast cancer (TNBC), where it enhanced the anticancer activity of taxanes (including docetaxel) by targeting cancer stem cells (CSCs). SFN suppressed IL-6 secretion and reversed CSC expansion typically induced by taxane treatment, thereby improving long-term therapeutic outcomes and reducing recurrence risk. These findings underscore SFN’s potential as a chemosensitizer, capable of lowering the required dose of cytotoxic drugs while maintaining efficacy, thereby minimizing adverse effects and overcoming resistance mechanisms.
5.2. Sulforaphane Sensitizes Cells to Radiation-Induced Apoptosis:
Sulforaphane (SFN) enhances the sensitivity of cancer cells to radiation-induced apoptosis, making it a promising radiosensitizer in oncologic therapy. As reviewed by Sailo et al. [60], SFN modulates multiple signaling pathways—including Akt/mTOR, NF-κB, and Wnt/β-catenin—that are commonly activated in radioresistant tumors. By downregulating anti-apoptotic proteins such as Bcl-2 and survivin, and upregulating pro-apoptotic mediators like p53, p21, and caspases, SFN primes cancer cells for enhanced apoptotic response following radiation exposure. This chemosensitizing effect is particularly evident in cancers of the bone, brain, and breast, where SFN synergistically augments radiation efficacy while minimizing damage to surrounding healthy tissue. SFN treatment in glioblastoma cells activated the ATF4–CHOP axis of the unfolded protein response (UPR), a pathway known to amplify radiation-induced stress and apoptosis[61]. SFN pre-treatment led to increased nuclear translocation of CHOP and elevated expression of ER stress markers, which sensitized glioma cells to subsequent radiation. Importantly, SFN showed minimal cytotoxicity in normal astrocytes, suggesting a favorable therapeutic window for combination therapy.
Together, these findings highlight SFN’s potential to overcome radioresistance, enhance tumor control, and reduce the required radiation dose, thereby improving therapeutic outcomes and minimizing side effects.
5.3. Reverses drug resistance by modulating ABC transporters:
Sulforaphane (SFN) has emerged as a potent modulator of ATP-binding cassette (ABC) transporters, which play a central role in multidrug resistance (MDR) by actively effluxing chemotherapeutic agents out of cancer cells. As reviewed by Coutinho et al. [62], SFN downregulates the expression of key ABC transporters such as ABCB1 (P-glycoprotein) and ABCG2, thereby enhancing intracellular drug accumulation and restoring chemosensitivity. This effect is particularly relevant in cancer stem cells (CSCs), which often exhibit elevated ABC transporter activity and contribute to tumor relapse and therapy failure. SFN’s ability to suppress ABC transporter expression is linked to its modulation of Wnt/β-catenin and NF-κB signaling pathways, both of which regulate MDR gene transcription. Supporting this, Sailo et al. [63] demonstrated that SFN enhances the efficacy of chemotherapeutic agents by inhibiting ABC transporter-mediated efflux, leading to increased drug retention and apoptosis in resistant cancer cells. Their comprehensive review highlights SFN’s role in chemosensitization, showing that it not only downregulates ABCB1 and ABCG2 but also interferes with Akt/mTOR and MAPK pathways that sustain drug resistance phenotypes. Together, these findings position SFN as a promising adjunct in cancer therapy, capable of reversing drug resistance and improving the therapeutic index of conventional anticancer agents.
6.1.SFN Increases Intracellular ROS, Promoting Oxidative Damage
Sulforaphane (SFN), though widely recognized for its antioxidant-inducing properties, can paradoxically act as a pro-oxidant in cancer cells, leading to oxidative stress and apoptosis. As demonstrated by Ferreira de Oliveira et al. [64], SFN treatment in p53-null MG-63 osteosarcoma cells significantly increased intracellular reactive oxygen species (ROS) levels in a dose-dependent manner. At concentrations ≥10 µM, SFN impaired glutathione recycling by inhibiting glutathione reductase (GR) and suppressing glutathione peroxidase (GPx) gene expression and activity. This disruption of redox homeostasis led to elevated ROS accumulation, caspase-3 activation, and early apoptotic events, confirming SFN’s cytotoxic potential via oxidative damage. Extending these findings, Liang et al. [65] showed that SFN induces a pro-oxidative state in human T-cells, marked by increased ROS and depleted glutathione (GSH) levels. This oxidative shift resulted in global cysteine sulfenylation and targeted oxidation of transcription factors like STAT3, impairing inflammatory signaling and promoting apoptosis. Notably, the effects were reversible with antioxidant supplementation, confirming the ROS-dependent nature of SFN’s cytotoxicity. Together, these studies highlight SFN’s dual role: while it activates detoxification pathways in normal cells via Nrf2, it can overwhelm antioxidant defenses in cancer cells, leading to selective oxidative damage and cell death—a mechanism exploitable for cancer therapy.
6.2. Sulforaphane Activates Nrf2 Pathway, Boosting Antioxidant Defenses
Sulforaphane (SFN) is a potent activator of the Nrf2 (nuclear factor erythroid 2–related factor 2) pathway, which governs the transcription of over 200 genes involved in antioxidant defense, detoxification, and cellular protection. As demonstrated by Kubo et al. [66], SFN enhances Nrf2 translocation into the nucleus, where it binds to antioxidant response elements (AREs) in the promoter regions of genes such as Prdx6, catalase, and GSTπ. This activation restores Nrf2/ARE signaling disrupted by aging and oxidative stress, leading to increased expression of cytoprotective enzymes and improved resistance to UVB-induced toxicity. SFN upregulates Nrf2-mediated antioxidant enzymes in colorectal cancer cells, including HO-1 and NQO1, in both p53-wild-type and p53-knockout models. The study confirmed SFN’s ability to modulate redox balance and mitochondrial function through Nrf2 activation, highlighting its dual role in cytoprotection and metabolic regulation[67].SFN modifies cysteine residues on Keap1, the cytoplasmic repressor of Nrf2, thereby releasing Nrf2 to initiate transcription of phase II detoxification enzymes such as UGT, GSTs, and NQO1. This cascade enhances cellular resilience against oxidative and xenobiotic stress[68].SFN-induced Nrf2 activation in human T-cells leads to increased glutathione synthesis and ROS neutralization, while simultaneously suppressing inflammatory signaling via STAT3 oxidation. These effects were shown to be reversible with antioxidant supplementation, confirming the redox-dependent nature of SFN’s action[69].Finally, Metabolic Therapy [70] summarized preclinical evidence showing that SFN activates Nrf2 by inhibiting Keap1, resulting in elevated expression of detoxifying enzymes and reduced oxidative damage across multiple cancer models. SFN’s ability to modulate Nrf2 makes it a promising agent for chemoprevention, anti-aging therapy, and inflammation control.
6.3. Phase II Detox Enzymes (e.g., GST, NQO1)
Sulforaphane (SFN), a bioactive isothiocyanate derived from cruciferous vegetables, is a well-established inducer of Phase II detoxification enzymes, which play a critical role in neutralizing reactive metabolites and enhancing cellular resilience. As described by Vitafenix [71], SFN activates the Nrf2–ARE pathway, leading to transcriptional upregulation of key detox enzymes including GST, NQO1, and UGT. This activation occurs via covalent modification of cysteine residues on Keap1, releasing Nrf2 to translocate into the nucleus and initiate gene expression. These enzymes catalyze conjugation reactions that render electrophilic toxins water-soluble for excretion, thereby reducing oxidative and xenobiotic stress. SFN’s potency in human keratinocytes, where it significantly increased GST and NQO1 activity after 48 hours of exposure. Their study emphasized the importance of the isothiocyanate functional group in SFN’s detoxifying action, showing that synthetic derivatives were less effective than native SFN[72]. SFN-rich broccoli sprout extract upregulated GSTM1 and NQO1 in human airway epithelial cells, with a dose-dependent increase in gene expression. This was further validated in a pilot clinical trial, where oral epithelial cells showed a twofold increase in NQO1 after SFN supplementation[73]. SFN’s ability to elevate intracellular glutathione (GSH) levels, enhancing the substrate pool for GST-mediated detoxification. Their findings support SFN’s role in maintaining redox balance and protecting against environmental insults[74].Finally, a randomized controlled trial summarized by Metabolic Therapy [75] showed that daily intake of SFN-rich broccoli sprout beverages significantly increased urinary excretion of airborne pollutants, correlating with elevated GST and NQO1 activity. These results underscore SFN’s translational potential in clinical detoxification protocols.
6.4. Sulforaphane Inhibits Phase I Enzymes That Activate Procarcinogens:
Sulforaphane (SFN) plays a critical role in blocking carcinogen activation by inhibiting Phase I enzymes, particularly cytochrome P450s (CYPs), which are responsible for converting procarcinogens into reactive intermediates. [76], SFN interferes with the initiation stage of carcinogenesis by downregulating CYP1A1, CYP1B1, and CYP3A4, thereby reducing the bioactivation of polycyclic aromatic hydrocarbons and heterocyclic amines. This inhibitory effect complements SFN’s induction of Phase II detoxification enzymes, creating a dual-action chemopreventive profile. SFN’s ability to suppress Phase I enzyme activity in liver and colon cancer models. Their study showed that SFN treatment led to decreased expression of CYP1A2 and CYP2E1, enzymes commonly involved in the metabolic activation of aflatoxins and nitrosamines[77]. This suppression was mediated through Nrf2-dependent transcriptional repression and epigenetic modulation. SFN-rich broccoli sprout extract reduced CYP1A1 expression in human breast epithelial cells, thereby lowering DNA adduct formation and mutagenic potential[78]. The study emphasized SFN’s role in blocking initiation rather than merely suppressing tumor progression. SFN’s impact on benzo[a]pyrene metabolism, showing that SFN inhibited CYP1A1-mediated activation and enhanced conjugation via GST, leading to reduced genotoxicity in lung epithelial cells[79]. SFN acts as a monofunctional inducer, selectively inhibiting Phase I enzymes while upregulating Phase II enzymes. Their work laid the groundwork for SFN’s classification as a blocking agent in carcinogen metabolism[80].
7.1. Suppresses PI3K/Akt/mTOR signaling:
Sulforaphane (SFN) exerts potent anticancer effects by suppressing the PI3K/Akt/mTOR signaling pathway, a central axis regulating cell survival, proliferation, and metabolism. As reviewed by Liu et al. [81], SFN inhibits phosphorylation of Akt and mTOR, leading to downstream suppression of cell cycle regulators and induction of apoptosis. This pathway is frequently hyperactivated in various cancers, and SFN’s ability to downregulate it contributes to its tumor-suppressive properties. In breast cancer models, demonstrated that SFN reduced PI3K/Akt/mTOR activity, promoting autophagy and apoptosis while enhancing the efficacy of chemotherapeutic agents. Their nanomedicine-based approach showed improved bioavailability and synergistic tumor suppression[82]. SFN, alone and in combination with formononetin, significantly reduced PI3K, Akt, and mTOR expression in HeLa cervical cancer cells, resulting in enhanced ROS generation and apoptotic signaling. This dual-agent strategy amplified SFN’s impact on cell cycle arrest and cytotoxicity[83]. SFN’s effects in endometrial cancer, confirming that SFN downregulated Akt and mTOR while modulating EMT markers. Proteomic analysis revealed that SFN altered kinase networks, reducing migration and invasion in vitro and in xenograft models[84]. Finally SFN suppressed PI3K/Akt signaling in glioblastoma cells, contributing to ER stress and apoptosis. SFN treatment led to increased CHOP expression and mitochondrial dysfunction, reinforcing its role in targeting survival pathways[85].
7.2. Modulates NF-κB Pathway, Reducing Inflammation:
Sulforaphane (SFN) exerts strong anti-inflammatory effects by modulating the NF-κB signaling pathway, which plays a pivotal role in regulating immune responses, cytokine production, and chronic inflammation. As demonstrated by Sailo et al., SFN inhibits the phosphorylation and degradation of IκBα, preventing the nuclear translocation of NF-κB p65, thereby suppressing transcription of pro-inflammatory genes such as TNF-α, IL-6, and IL-1β. This results in reduced inflammatory cytokine secretion and diminished oxidative stress in cancer and immune cells [86]. In macrophage models, SFN was shown to attenuate LPS-induced NF-κB activation, leading to decreased expression of COX-2 and iNOS, and promoting a shift toward an anti-inflammatory phenotype [87]. Similarly, in human bronchial epithelial cells, SFN suppressed NF-κB signaling and reduced neutrophil recruitment, suggesting its utility in respiratory inflammatory disorders [88]. In colon cancer cells, SFN downregulated NF-κB target genes involved in proliferation and angiogenesis, including VEGF and MMP-9, thereby linking its anti-inflammatory action to anti-metastatic effects [89]. SFN also demonstrated protective effects in neuroinflammation models, where it reduced microglial activation and inhibited NF-κB-mediated neurotoxic cytokine release [90]. Furthermore, SFN’s modulation of NF-κB is partly mediated through Nrf2 cross-talk, where activation of antioxidant response elements indirectly suppresses NF-κB-driven inflammation, Activates JNK and p38 MAPK Pathways Sulforaphane (SFN) modulates key stress-responsive signaling cascades by activating the JNK and p38 MAPK pathways, which are involved in inflammation, apoptosis, and immune regulation. As demonstrated by Deramaudt et al., SFN pretreatment of macrophages exposed to Staphylococcus aureus led to phosphorylation of JNK and p38 MAPK, enhancing bactericidal activity and reducing intracellular pathogen survival. This activation was associated with downregulation of proinflammatory microRNAs (miR-142-5p and miR-146a-5p) and suppression of cytokines such as IL-1β, IL-6, and TNF-α, indicating SFN’s role in fine-tuning immune responses through MAPK signaling [92]. In colorectal cancer cells, SFN was shown to activate MAPK/AP-1 signaling, leading to reduced IL-6 expression and inhibition of cell proliferation and invasion [93]. Similarly, in hepatoma HepG2 cells, SFN enhanced ARE-mediated transcription of antioxidant genes via p38 MAPK-dependent phosphorylation of Nrf2, demonstrating its dual role in stress response and detoxification [94]. Further evidence from breast cancer models revealed that SFN-induced JNK activation promotes apoptosis through mitochondrial disruption and caspase-3 cleavage [95]. In neuronal cells, SFN activated p38 MAPK and JNK to mitigate oxidative damage and support neuroprotection, highlighting its therapeutic potential beyond oncology [96]. Collectively, these findings underscore SFN’s ability to engage JNK and p38 MAPK pathways as part of its multifaceted mechanism, contributing to inflammation control, apoptosis induction, and cellular defense.
7.3.Inhibits Wnt/β-Catenin Signaling, Reducing Stemness
Sulforaphane (SFN) exerts potent anti-cancer effects by inhibiting Wnt/β-catenin signaling, a pathway crucial for maintaining cancer stem cell (CSC) properties and tumor progression. Bernkopf et al. demonstrated that SFN suppresses Wnt/β-catenin activity in colorectal cancer cells by interfering with β-catenin–TCF transcriptional complex formation, independent of upstream β-catenin degradation. SFN treatment reduced expression of canonical Wnt target genes such as AXIN2 and LGR5, both markers of stemness, and induced nuclear β-catenin sequestration into transcriptionally inactive chromatin domains. This disruption of Wnt signaling led to decreased proliferation and enhanced apoptosis in SW480, DLD1, and HCT116 cells [97]. In breast cancer stem-like cells, SFN downregulated β-catenin and cyclin D1, impairing self-renewal and mammosphere formation, indicating suppression of CSC traits [98]. Similarly, SFN reduced stemness in prostate cancer by targeting Wnt/β-catenin and SHH pathways, leading to diminished ALDH1 activity and CD44 expression [99]. In glioblastoma models, SFN inhibited Wnt signaling and reduced SOX2 and Nestin, key regulators of neural stemness, thereby sensitizing cells to chemotherapeutics [100]. Moreover, SFN synergized with doxorubicin in cardiac models by modulating Wnt/β-catenin and antioxidant responses, suggesting broader implications in stemness and stress adaptation [101]. These findings highlight SFN’s ability to attenuate cancer stemness through targeted inhibition of Wnt/β-catenin signaling, offering a promising strategy for overcoming therapy resistance and tumor recurrence.
7.3. Selectivity & Safety
Exhibits selective cytotoxicity toward cervical cancer cells, sparing normal epithelial cells Sulforaphane (SFN) demonstrates selective cytotoxicity by preferentially targeting cervical cancer cells while sparing normal epithelial cells, underscoring its therapeutic safety profile. Luo et al. showed that SFN significantly inhibited proliferation and induced apoptosis in HeLa cells via downregulation of miR-1247-3p, which in turn activated the MAPK signaling pathway. Importantly, SFN exhibited minimal cytotoxicity toward non-cancerous cervical epithelial cells, suggesting a tumor-specific mechanism of action. These findings were validated through flow cytometry, Western blot, and qRT-PCR analyses, confirming SFN’s ability to modulate gene expression and promote cancer cell death without harming normal tissue [102].In a comparative study, SFN induced dose-dependent apoptosis in HeLa cells while maintaining viability in normal keratinocytes, highlighting its selective oxidative stress induction in malignant cells [103]. Similarly, SFN treatment led to G2/M cell cycle arrest in cervical cancer cells, with no significant impact on non-transformed cells, indicating differential checkpoint sensitivity [104].Further evidence from in vivo models revealed that SFN reduced tumor volume in xenografted cervical cancer mice without affecting surrounding healthy tissues, reinforcing its low systemic toxicity [105]. Additionally, SFN’s selective action was attributed to its ability to modulate ROS levels and mitochondrial membrane potential specifically in cancer cells, sparing normal cells from oxidative damage [106]Together, these studies affirm SFN’s selective cytotoxicity and safety, making it a promising candidate for cervical cancer therapy with minimal off-target effects.
Sulforaphane (SFN) holds significant promise as a future therapeutic agent for cervical cancer, offering a multi-targeted approach with minimal toxicity. Luo et al. provided compelling evidence that SFN suppresses cervical cancer cell viability and induces apoptosis via downregulation of miR-1247-3p and subsequent activation of the MAPK signaling pathway. Using next-generation sequencing (NGS) and bioinformatics analysis, the study identified SFN’s ability to modulate key oncogenic transcripts and microRNAs, suggesting its potential for precision medicine applications. These findings lay the groundwork for SFN’s integration into cervical cancer treatment regimens, especially for patients resistant to conventional therapies [107]In a recent study, SFN was shown to enhance radiosensitivity in cervical cancer cells by activating LATS2 and inhibiting homologous recombination repair via suppression of Rad51/MDC1 nuclear recruitment, thereby improving radiotherapy outcomes [108]. Additionally, SFN’s ability to modulate epigenetic regulators and oxidative stress pathways positions it as a candidate for chemo-radioprotective strategies [109].SFN also demonstrated efficacy in reducing tumor stemness and recurrence by targeting Wnt/β-catenin and Notch pathways, which are often upregulated in cervical cancer stem-like cells [110]. Moreover, its anti-inflammatory and antioxidant properties, mediated through Nrf2 activation and NF-κB inhibition, suggest long-term benefits in preventing HPV-induced carcinogenesis and progression [111].Collectively, these studies highlight SFN’s potential to transform cervical cancer therapy by offering a safe, multi-modal, and biologically precise intervention that complements existing treatments and addresses unmet clinical needs.
Sulforaphane (SFN) is a potent phytochemical with selective cytotoxicity against cervical cancer cells, sparing normal epithelial tissue. It activates stress-responsive pathways like JNK and p38 MAPK, promoting apoptosis and immune modulation. SFN inhibits Wnt/β-catenin signaling, reducing cancer stemness, self-renewal, and metastatic potential. It enhances radiosensitivity by disrupting DNA repair proteins such as Rad51 and MDC1.SFN modulates oncogenic microRNAs, including miR-1247-3p, contributing to transcriptional reprogramming. Through Nrf2 activation and NF-κB suppression, it supports antioxidant defense and reduces HPV-driven inflammation. In vivo studies confirm its tumor-reducing effects with minimal systemic toxicity. Its epigenetic influence adds value in long-term cancer prevention strategies. SFN’s oral bioavailability and dietary origin make it accessible and safe. It complements existing therapies and may reduce treatment-related side effects. Future clinical validation is needed to establish its role in personalized oncology. Overall, SFN offers a multi-targeted, low-toxicity approach to cervical cancer therapy.
Dear Editorial Team, Clinical Medical Reviews and Reports. My experience with the journal was highly positive. The peer-review process was rigorous, constructive, and completed in a timely manner. The reviewers provided valuable comments that helped improve the quality and clarity of our manuscript. The editorial office was professional, responsive, and supportive throughout all stages of the publication process. Communication was clear and efficient, and any questions were addressed promptly. Overall, I found the journal to maintain high scientific standards and an excellent publication workflow. I would be pleased to consider submitting future work to this journal. Best wishes from, Elena Popa.
It was my pleasure to submit my testimonial concerning the Reviewer Board of our Scientific Journal “Brain and Neurological Disorders”. The Reviewers focused on some modifications and their contribution was helpful. The ladies of our Editorial Office were also supported my efforts. It was my honor to have such a co-operation and I am looking forward for more collaboration.
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Thank you for the speedy and efficient peer review process. I appreciate the fact that your peer reviewers do not take months to respond like with some other journals. I would also like to thank the editorial office for responding quickly to my questions. It is an excellent journal. I plan to submit more manuscripts in the future. Best wishes from, Robert W. McGee
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Working with you and your team on our recent publication in JCRR has been a truly wonderful and enjoyable experience. The responses were prompt, and the reviewers were patient, constructive, and highly professional. One reviewer in particular gave me the feeling that a professor was carefully reading and commenting on my coursework, which was deeply touching. The entire process was straightforward and hassle‑free, with no tedious online forms to complete. I highly recommend this journal. Best wishes from, DR Aibing Rao, Head of R&D
I Appreciate the Opportunity to Share my Experience with the Journal of Clinical Research and Reports. The peer review process was timely and constructive, and the feedback provided helped improve the quality of our manuscript. The editorial office was professional, responsive, and supportive throughout the process, ensuring smooth communication and efficient handling of the submission. Overall, it was a positive experience collaborating with your team.
Dear Mercy Grace, Editorial Coordinator of Obstetrics Gynecology and Reproductive Sciences, We would like to express our gratitude for your help at all stages of publishing and editing the article. The editors of the magazine answer all the necessary questions and help at every stage. We will definitely continue to cooperate and publish other works in the Obstetrics Gynecology and Reproductive Sciences! Best wishes from, Alla Konstantinovna Politova,
Dear Maria Emerson, Editorial Coordinator of International Journal of Clinical Case Reports and Reviews, What distinguishes International Journal of Clinical Case Report and Review is not only the scientific rigor of its publications, but the intellectual climate in which research is evaluated. The submission process is refreshingly free of unnecessary formal barriers and bureaucratic rituals that often complicate academic publishing without adding real value. The peer-review system is demanding yet constructive, guided by genuine scientific dialogue rather than hierarchical or authoritarian attitudes. Reviewers act as collaborators in improving the manuscript, not as gatekeepers imposing arbitrary standards. This journal offers a rare balance: high methodological standards combined with a respectful, transparent, and supportive editorial approach. In an era where publishing can feel more burdensome than research itself, this platform restores the original purpose of peer review — to refine ideas, not to obstruct them Prof. Perlat Kapisyzi, FCCP PULMONOLOGIST AND THORACIC IMAGING.
Dear Reader: We have published several articles in the Auctores Publishing, LLC, journal, Clinical Medical Reviews and Reports in recent years (CMRR). This is an ‘open access’ journal and the following are our observations. From the initial invitation to submit an article, to the final edits of galley proofs, we have found CMRR personnel to be professional, responsive, rapid and thorough. This entire process begins with Catherine Mitchell, Editorial Coordinator. She is simply outstanding, and, I believe, unparalleled in her capacity. I cannot imagine a more responsive and dedicated Editorial Coordinator. As I read the dates and timing of her correspondence with us, it seems that she never sleeps. I hope Auctores Publishing, LLC, appreciates her efforts as much as these authors do. Thank you to Auctores Publishing, LLC, to the Editorial Staff/Board, and to Catherine Mitchell from a grateful author(s).
Dear Maria Emerson, Editorial Coordinator of - Journal of Clinical Research and Reports. ''I am pleased to provide this testimonial following the publication of our recent case report in this journal. The peer review process was rigorous, constructive, thorough, and conducted in a timely manner. The reviewers’ comments were thoughtful, detailed, and highly constructive, contributing substantially to the refinement, clarity, and scientific robustness of our manuscript. The process was conducted with professionalism and academic integrity throughout. The support provided by the editorial office was exemplary. Communication was consistently prompt, clear, and courteous at all stages of the submission and publication process. The editorial team demonstrated a high level of organization and responsiveness, ensuring that all queries were addressed efficiently and that the process remained transparent and well-coordinated. The overall quality of the journal is reflected in its strong editorial standards, commitment to scientific excellence, and dedication to publishing clinically meaningful research. It has been a privilege to publish our work in this journal, and we would welcome the opportunity to contribute further in the future.'' Best wishes from, Dr. Efstratios Trogkanis, Cardiologist.
Dear Grace Pierce, Editorial Coordinator of the journal IJCCR, I had a very positive experience with Auctores - Journal throughout the publication process. The Editorial Team was highly responsive, professional, and supportive at every stage. I would like to extend my sincere thanks to the Editor: Grace Pierce, for her guidance and assistance. The peer-review process was smooth and constructive, helping improve the quality of my work. I would gladly recommend Auctores Journal to fellow researchers and authors. Dr. SABITA SINHA, Medical Oncologist, MD (Electro Homeopathy).
Dear Mayra Duenas, Editorial Coordinator of the journal IJCCR, I write here a little on my experience as an author submitting to the International Journal of Clinical Case Reports and Reviews (IJCCR). This was my first submission to IJCCR and my manuscript was inherently an outsider’s effort. It attempted to broadly identify and then make some sense of life’s under-appreciated mysteries. I initially had responded to a request for possible submissions. I then contacted IJCCR with a tentative topic for a manuscript. They quickly got back with an approval for the submission, but with a particular requirement that it be medically relevant. I then put together a manuscript and submitted it. After the usual back-and-forth over forms and formality, the manuscript was sent off for reviews. Within 2 weeks I got back 4 reviews which were both helpful and also surprising. Surprising in that the topic was somewhat foreign to medical literature. My subsequent updates in response to the reviewer comments went smoothly and in short order I had a series of proofs to evaluate. All in all, the whole publication process seemed outstanding. It was both helpful in terms of the paper’s content and also in terms of its efficient and friendly communications. Thank you all very much. Sincerely, Ted Christopher, Rochester, NY.
International Journal of Clinical Case Reports and Reviews is a high quality journal that has a clear and concise submission process. The peer review process was comprehensive and constructive. Support from the editorial office was excellent, since the administrative staff were responsive. The journal provides a fast and timely publication timeline.
Dear Cecilia Lilly, Editorial Coordinator, Endocrinology and Disorders, Thank you so much for your quick response regarding reviewing and all process till publishing our manuscript entitled: Prevalence of Pre-Diabetes and its Associated Risk Factors Among Nile College Students, Sudan. Best regards, Dr Mamoun Magzoub.
Dear Editorial Team, Clinical Cardiology and Cardiovascular Interventions. I am really grateful for the peers review; their feedback gave me the opportunity to reflect on the message and impact of my work and to ameliorate the article. The editors did a great job in addition by encouraging me to continue with the process of publishing.
Dear Mayra Duenas, Editorial Coordinator of ‘International Journal of Clinical Case Reports and Reviews Herewith I confirm an optimal peer review process and a great support of the editorial office of the present journal
Dear Maria Emerson, Editorial Coordinator of ‘International Journal of Clinical Case Reports and Reviews’, I appreciate the opportunity to publish my article with your journal. The editorial office provided clear communication during the submission and review process, and I found the overall experience professional and constructive. Best regards, Elena Salvatore.
Dear Editorial Team, Journal-Clinical Cardiology and Cardiovascular Interventions, “Publishing my article with Clinical Cardiology and Cardiovascular Interventions has been a highly positive experience. The peer-review process was rigorous yet supportive, offering valuable feedback that strengthened my work. The editorial team demonstrated exceptional professionalism, prompt communication, and a genuine commitment to maintaining the highest scientific standards. I am very pleased with the publication quality and proud to be associated with such a reputable journal.” Warm regards, Dr. Mahmoud Kamal Moustafa Ahmed
Dear Editorial Team, Clinical Cardiology and Cardiovascular Interventions. It was truly a rewarding experience to work with the journal “Clinical Cardiology and Cardiovascular Interventions”. The peer review process was insightful and encouraging, helping us refine our work to a higher standard. The editorial office offered exceptional support with prompt and thoughtful communication. I highly value the journal’s role in promoting scientific advancement and am honored to be part of it. Best regards, Meng-Jou Lee, MD, Department of Anesthesiology, National Taiwan University Hospital.
Dear Maria Emerson, Editorial Coordinator, Journal of Clinical Research and Reports. Thank you for publishing our case report: "Clinical Case of Effective Fetal Stem Cells Treatment in a Patient with Autism Spectrum Disorder" within the "Journal of Clinical Research and Reports" being submitted by the team of EmCell doctors from Kyiv, Ukraine. We much appreciate a professional and transparent peer-review process from Auctores. All research Doctors are so grateful to your Editorial Office and Auctores Publishing support! I amiably wish our article publication maintained a top quality of your International Scientific Journal. My best wishes for a prosperity of the Journal of Clinical Research and Reports. Hope our scientific relationship and cooperation will remain long lasting. Thank you very much indeed. Kind regards, Dr. Andriy Sinelnyk Cell Therapy Center EmCell
I recommend without hesitation submitting relevant papers on medical decision making to the International Journal of Clinical Case Reports and Reviews. I am very grateful to the editorial staff. Maria Emerson was a pleasure to communicate with. The time from submission to publication was an extremely short 3 weeks. The editorial staff submitted the paper to three reviewers. Two of the reviewers commented positively on the value of publishing the paper. The editorial staff quickly recognized the third reviewer’s comments as an unjust attempt to reject the paper. I revised the paper as recommended by the first two reviewers.
Dear Chrystine Mejia, Editorial Coordinator, Journal of Neurodegeneration and Neurorehabilitation. “The peer review process was efficient and constructive, and the editorial office provided excellent communication and support throughout. The journal ensures scientific rigor and high editorial standards, while also offering a smooth and timely publication process. We sincerely appreciate the work of the editorial team in facilitating the dissemination of innovative approaches such as the Bonori Method.” Best regards, Dr. Matteo Bonori.
Dear Maria Emerson, Editorial Coordinator, we have deeply appreciated the professionalism demonstrated by the International Journal of Clinical Case Reports and Reviews. The reviewers have extensive knowledge of our field and have been very efficient and fast in supporting the process. I am really looking forward to further collaboration. Thanks. Best regards, Dr. Claudio Ligresti
Dear Ms. Mayra Duenas, Editorial Coordinator, International Journal of Clinical Case Reports and Reviews. “The International Journal of Clinical Case Reports and Reviews represented the “ideal house” to share with the research community a first experience with the use of the Simeox device for speech rehabilitation. High scientific reputation and attractive website communication were first determinants for the selection of this Journal, and the following submission process exceeded expectations: fast but highly professional peer review, great support by the editorial office, elegant graphic layout. Exactly what a dynamic research team - also composed by allied professionals - needs!" From, Chiara Beccaluva, PT - Italy.
Dear Clarissa Eric, Editorial Coordinator, Journal of Clinical Case Reports and Studies, Auctores Publishing LLC, USA Office: +1-(302)-520-2644. I would like to express my sincere appreciation for the efficient and professional handling of my case report by the ‘Journal of Clinical Case Reports and Studies’. The peer review process was not only fast but also highly constructive—the reviewers’ comments were clear, relevant, and greatly helped me improve the quality and clarity of my manuscript. I also received excellent support from the editorial office throughout the process. Communication was smooth and timely, and I felt well guided at every stage, from submission to publication. The overall quality and rigor of the journal are truly commendable. I am pleased to have published my work with Journal of Clinical Case Reports and Studies, and I look forward to future opportunities for collaboration. Sincerely, Aline Tollet, UCLouvain.
Dear Chrystine Mejia, Editorial Coordinator, Journal of Neurodegeneration and Neurorehabilitation, Auctores Publishing LLC, We would like to thank the editorial team for the smooth and high-quality communication leading up to the publication of our article in the Journal of Neurodegeneration and Neurorehabilitation. The reviewers have extensive knowledge in the field, and their relevant questions helped to add value to our publication. Kind regards, Dr. Ravi Shrivastava.
Dear Clarissa Eric, Editorial Coordinator, Journal of Clinical Case Reports and Studies, I would like to express my deep admiration for the exceptional professionalism demonstrated by your journal. I am thoroughly impressed by the speed of the editorial process, the substantive and insightful reviews, and the meticulous preparation of the manuscript for publication. Additionally, I greatly appreciate the courteous and immediate responses from your editorial office to all my inquiries. Best Regards, Dariusz Ziora
Dear Ashley Rosa, Editorial Coordinator, International Journal of Clinical Case Reports and Reviews, Auctores Publishing LLC. Thank you for publishing our article, Exploring Clozapine's Efficacy in Managing Aggression: A Multiple Single-Case Study in Forensic Psychiatry in the international journal of clinical case reports and reviews. We found the peer review process very professional and efficient. The comments were constructive, and the whole process was efficient. On behalf of the co-authors, I would like to thank you for publishing this article. With regards, Dr. Jelle R. Lettinga.
Dear Jessica Magne, Editorial Coordinator, Clinical Cardiology and Cardiovascular Interventions, Auctores Publishing LLC. The peer review process of the journal of Clinical Cardiology and Cardiovascular Interventions was excellent and fast, as was the support of the editorial office and the quality of the journal. Kind regards Walter F. Riesen Prof. Dr. Dr. h.c. Walter F. Riesen.
Dear Erin Aust, Editorial Coordinator, Journal of General Medicine and Clinical Practice. We are pleased to share our experience with the “Journal of General Medicine and Clinical Practice”, following the successful publication of our article. The peer review process was thorough and constructive, helping to improve the clarity and quality of the manuscript. We are especially thankful to Ms. Erin Aust, the Editorial Coordinator, for her prompt communication and continuous support throughout the process. Her professionalism ensured a smooth and efficient publication experience. The journal upholds high editorial standards, and we highly recommend it to fellow researchers seeking a credible platform for their work. Best wishes By, Dr. Rakhi Mishra.
Dr Hala Al Shaikh This is to acknowledge that the peer review process for the article ’ A Novel Gnrh1 Gene Mutation in Four Omani Male Siblings, Presentation and Management ’ sent to the International Journal of Clinical Case Reports and Reviews was quick and smooth. The editorial office was prompt with easy communication.
Dear Agrippa Hilda, Editorial Coordinator, Journal of Neuroscience and Neurological Surgery. The entire process including article submission, review, revision, and publication was extremely easy. The journal editor was prompt and helpful, and the reviewers contributed to the quality of the paper. Thank you so much! Eric Nussbaum, MD
Dear Ashley Rosa, Editorial Coordinator, International Journal of Clinical Case Reports and Reviews. Many thanks for publishing this manuscript after I lost confidence the editors were most helpful, more than other journals Best wishes from, Susan Anne Smith, PhD. Australian Breastfeeding Association.
Dear Maria Emerson, Editorial Coordinator, International Journal of Clinical Case Reports and Reviews, Auctores Publishing LLC. I am delighted to have published our manuscript, "Acute Colonic Pseudo-Obstruction (ACPO): A rare but serious complication following caesarean section." I want to thank the editorial team, especially Maria Emerson, for their prompt review of the manuscript, quick responses to queries, and overall support. Yours sincerely Dr. Victor Olagundoye.
Dear Jessica Magne, Editorial Coordinator, Clinical Cardiology and Cardiovascular Interventions, Auctores Publishing LLC. I appreciate the journal (JCCI) editorial office support, the entire team leads were always ready to help, not only on technical front but also on thorough process. Also, I should thank dear reviewers’ attention to detail and creative approach to teach me and bring new insights by their comments. Surely, more discussions and introduction of other hemodynamic devices would provide better prevention and management of shock states. Your efforts and dedication in presenting educational materials in this journal are commendable. Best wishes from, Farahnaz Fallahian.
Dear Ashley Rosa, Editorial Coordinator of the journal - Psychology and Mental Health Care. " The process of obtaining publication of my article in the Psychology and Mental Health Journal was positive in all areas. The peer review process resulted in a number of valuable comments, the editorial process was collaborative and timely, and the quality of this journal has been quickly noticed, resulting in alternative journals contacting me to publish with them." Warm regards, Susan Anne Smith, PhD. Australian Breastfeeding Association.
Dear Jessica, and the super professional team of the ‘Clinical Cardiology and Cardiovascular Interventions’ I am sincerely grateful to the coordinated work of the journal team for the no problem with the submission of my manuscript: “Cardiometabolic Disorders in A Pregnant Woman with Severe Preeclampsia on the Background of Morbid Obesity (Case Report).” The review process by 5 experts was fast, and the comments were professional, which made it more specific and academic, and the process of publication and presentation of the article was excellent. I recommend that my colleagues publish articles in this journal, and I am interested in further scientific cooperation. Sincerely and best wishes, Dr. Oleg Golyanovskiy.
To Dear Erin Aust – Editorial Coordinator of Journal of General Medicine and Clinical Practice! I declare that I am absolutely satisfied with your work carried out with great competence in following the manuscript during the various stages from its receipt, during the revision process to the final acceptance for publication. Thank Prof. Elvira Farina
My article, titled 'No Way Out of the Smartphone Epidemic Without Considering the Insights of Brain Research,' has been republished in the International Journal of Clinical Case Reports and Reviews. The review process was seamless and professional, with the editors being both friendly and supportive. I am deeply grateful for their efforts.
We found the peer review process quick and positive in its input. The support from the editorial officer has been very agile, always with the intention of improving the article and taking into account our subsequent corrections.
Dear Jessica Magne, with gratitude for the joint work. Fast process of receiving and processing the submitted scientific materials in “Clinical Cardiology and Cardiovascular Interventions”. High level of competence of the editors with clear and correct recommendations and ideas for enriching the article.
I thank the ‘Journal of Clinical Research and Reports’ for accepting this article for publication. This is a rigorously peer reviewed journal which is on all major global scientific data bases. I note the review process was prompt, thorough and professionally critical. It gave us an insight into a number of important scientific/statistical issues. The review prompted us to review the relevant literature again and look at the limitations of the study. The peer reviewers were open, clear in the instructions and the editorial team was very prompt in their communication. This journal certainly publishes quality research articles. I would recommend the journal for any future publications.
"I am grateful for the opportunity of contributing to [International Journal of Clinical Case Reports and Reviews] and for the rigorous review process that enhances the quality of research published in your esteemed journal. I sincerely appreciate the time and effort of your team who have dedicatedly helped me in improvising changes and modifying my manuscript. The insightful comments and constructive feedback provided have been invaluable in refining and strengthening my work".
To Dear Erin Aust, I would like to express my heartfelt appreciation for the opportunity to have my work published in this esteemed journal. The entire publication process was smooth and well-organized, and I am extremely satisfied with the final result. The Editorial Team demonstrated the utmost professionalism, providing prompt and insightful feedback throughout the review process. Their clear communication and constructive suggestions were invaluable in enhancing my manuscript, and their meticulous attention to detail and dedication to quality are truly commendable. Additionally, the support from the Editorial Office was exceptional. From the initial submission to the final publication, I was guided through every step of the process with great care and professionalism. The team's responsiveness and assistance made the entire experience both easy and stress-free. I am also deeply impressed by the quality and reputation of the journal. It is an honor to have my research featured in such a respected publication, and I am confident that it will make a meaningful contribution to the field.
I would like to express my sincere gratitude for the support and efficiency provided by the editorial office throughout the publication process of my article, “Delayed Vulvar Metastases from Rectal Carcinoma: A Case Report.” I greatly appreciate the assistance and guidance I received from your team, which made the entire process smooth and efficient. The peer review process was thorough and constructive, contributing to the overall quality of the final article. I am very grateful for the high level of professionalism and commitment shown by the editorial staff, and I look forward to maintaining a long-term collaboration with the International Journal of Clinical Case Reports and Reviews.
Dear Agrippa Hilda- Editorial Coordinator of Journal of Neuroscience and Neurological Surgery, "The peer review process was very quick and of high quality, which can also be seen in the articles in the journal. The collaboration with the editorial office was very good."
I would like to offer my testimony in the support. I have received through the peer review process and support the editorial office where they are to support young authors like me, encourage them to publish their work in your esteemed journals, and globalize and share knowledge globally. I really appreciate your journal, peer review, and editorial office.
My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.
My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
